| Literature DB >> 32722388 |
Shehreen Amjad1, Md Saidur Rahman1, Myung-Geol Pang1.
Abstract
Bisphenol A (BPA) is an oestrogenic endocrine disruptor widely used in the production of certain plastics, e.g., polycarbonate, hard and clear plastics, and epoxy resins that act as protective coating for food and beverage cans. Human exposure to this chemical is thought to be ubiquitous. BPA alters endocrine function, thereby causing many diseases in human and animals. In the last few decades, studies exploring the mechanism of BPA activity revealed a direct link between BPA-induced oxidative stress and disease pathogenesis. Antioxidants, reducing agents that prevent cellular oxidation reactions, can protect BPA toxicity. Although the important role of antioxidants in minimizing BPA stress has been demonstrated in many studies, a clear consensus on the associated mechanisms is needed, as well as the directives on their efficacy and safety. Herein, considering the distinct biochemical properties of BPA and antioxidants, we provide a framework for understanding how antioxidants alleviate BPA-associated stress. We summarize the current knowledge on the biological function of enzymatic and non-enzymatic antioxidants, and discuss their practical potential as BPA-detoxifying agents.Entities:
Keywords: antioxidants; bisphenol A; diseases; endocrine disruptors; stress
Year: 2020 PMID: 32722388 PMCID: PMC7465987 DOI: 10.3390/biom10081105
Source DB: PubMed Journal: Biomolecules ISSN: 2218-273X
Figure 1Mechanisms of Bisphenol A (BPA) activity. Genomic, non-genomic, and direct effects exerted by BPA are depicted. See the main text for details. BPA, bisphenol A; DMR, differentially methylated regions; cER, cytoplasmic oestrogen receptor; Cyt-C, cytochrome c; GPCR, G protein-coupled receptor; MAPK, mitogen-activated protein kinase; mER, membrane-bound oestrogen receptor; nER, nuclear oestrogen receptor; PI3K, phosphatidylinositol 3-kinase; ROS, reactive oxygen species; TF, transcription factor.
Figure 2Overview of antioxidant defence systems in cell. See the main text for details.
Summary of the antioxidant effects alleviating bisphenol A (BPA) toxicity: evidence from in vivo models.
| BPA Dose | Target Antioxidant | Experimental Design | Mechanism of Action | Reference |
|---|---|---|---|---|
| 5, 50, and 500 µg/kg bodyweight/d | Superoxide dismutase (SOD) | 8-week-old male rats were exposed to BPA for 8 weeks | SOD levels in the liver were decreased by the higher dose tested | [ |
| 0, 2, 10, and 50 mg/kg bodyweight/d | 50-d-old male rats were treated with BPA for 30 d | SOD levels were reduced by the highest concentration tested | [ | |
| 20 and 100 mg/kg bodyweight/d | Male albino rats were exposed to BPA for 30 d | SOD levels decreased in the liver and testis | [ | |
| 5, 50, and 500 µg/kg bodyweight/d | Catalase (CAT) | 8-week-old male rats were exposed to BPA for 8 weeks | CAT levels in the liver were reduced upon exposure to the highest dose | [ |
| 0, 2, 10, and 50 mg/kg bodyweight/d | 50-d-old male rats were treated with BPA for 30 d | CAT levels in the liver were reduced in a dose-dependent manner | [ | |
| 50 and 25 mg/kg bodyweight/d | Male mice were given BPA intraperitoneally for 5 d | CAT activity was significantly reduced in the liver | [ | |
| 20 and 100 mg/kg bodyweight/d | Glutathione (GSH) | Male rats were exposed to BPA for 30 d | GSH levels decreased in the testis and liver | [ |
| 0.1, 1, 10, and 50 mg/kg bodyweight/d | Male rats were given BPA for 4 weeks | GSH levels decreased in the liver and reactive oxygen species (ROS) levels increased | [ | |
| 50 and 25 mg/kg bodyweight/day | Male mice were given BPA intraperitoneally for 5 d | GSH levels decreased in the kidney but were unchanged in the liver | [ | |
| 5, 50, and 500 µg/kg bodyweight/d | Uric acid | 6-week-old male mice were given BPA for 8 weeks | BPA decreased hepatic uric acid levels | [ |
| 25 and 10 mg/kg bodyweight/d | Adult male rats were administered BPA for 6 and 10 weeks | Both dosages increased uric acid levels in the kidney leading to its malfunction | [ | |
| 0.2, 2, and 20 µg/kg bodyweight/d | Vitamin C, 40 mg/kg bodyweight/d | Male rats were exposed to BPA for 60 d | Vitamin C had a protective effect on the epididymis in BPA-exposed rats | [ |
| 60 µg/kg bodyweight/day | Vitamin C, 150 mg/kg bodyweight/d | Female rats were co-administered BPA and Vitamin C for 20 d | BPA reduced the volume of the ovary cortex and medulla, and the volume of oocyte; vitamin C treatment alleviated these effects | [ |
| 25 mg/kg bodyweight/d | Vitamin C, 60 and 5.5 mg/kg bodyweight/d | Rats co-administered BPA and Vitamin C for 6 weeks | Vitamin C co-treatment reduced BPA hepatotoxicity and nephrotoxicity | [ |
| 5, 50, 100 μg/100 g bodyweight /d | Vitamin E, 4 mg /100 g bodyweight/d | 3-month-old male rats were co-administered BPA and Vitamin E for 3 months | Vitamin E protected the testicular cells and epididymal sperm from apoptosis in BPA-exposed rats | [ |
| 20 mg/kg bodyweight/d | Vitamin E, 200 mg/kg bodyweight/d | Male rats were treated for 15 d | BPA enhanced lipid peroxidation in the blood; this was alleviated by vitamin E | [ |
| 20 mg/kg bodyweight/d | Vitamin E, 0.57 mg /100 g bodyweight/d | 6 to 8-week-old female rats were treated for 15 d | Vitamin E restored the function of hypothalamus–pituitary–gonadal axis in BPA-exposed rats | [ |
| 50 mg/kg bodyweight/d | Vitamin A, 3000 IU | 10 to 12-week-old male mice were treated for 3 d | Vitamin A co-administration alleviated BPA toxicity in the liver | [ |
| 50 µg/d | Vitamin A, 100 IU | Male mice were co-administered BPA and Vitamin A for 5 d from the day of birth | Treatment with vitamin A increased sperm motility | [ |
| 100 mg/kg bodyweight/d | Vitamin A, 5 mg/kg bodyweight/d | 10 to 11-week-old female rats were co-administered BPA and Vitamin A for 3 d | Vitamin A minimized epithelium cell proliferation in BPA-exposed mice | [ |
| 10 mg/kg bodyweight/d | Melatonin, 10 mg/kg bodyweight/d | Male mice were co-administered BPA and melatonin for 14 d | Melatonin reduced mitochondrial toxicity in the testis of BPA-exposed rats | [ |
| 50 mg/kg bodyweight /d | Melatonin, 10 mg/kg bodyweight/d | 8-week-old male rats were co-administered BPA and melatonin for 6 weeks | Melatonin improved GSH, SOD, CAT, malondialdehyde, and H2O2 levels in mice co-treated with BPA | [ |
| 200 mg/kg bodyweight/d | Melatonin, 10 mg/kg bodyweight/d | 8-week-old male rats were co-administered for 10 d | Melatonin repaired DNA damage in male germ cells by suppressing the oxidative stress in BPA-treated rats | [ |
| 50 mg/kg bodyweight/d | Quercetin, 50 mg/kg bodyweight/d | Adult male rats were co-administered BPA and quercetin for 52 d | Quercetin reduced plasma total cholesterol, triglyceride, and low-density lipoprotein cholesterol levels in BPA-treated rats | [ |
| 50 and 100 mg/kg bodyweight/d | Quercetin, 10 mg/kg bodyweight/d | Adult male mice were co-administered BPA and quercetin for 6 weeks | Quercetin reduced abnormal testis weight, and improved sperm quality and quantity in BPA-exposed mice | [ |
| 10 mg/kg bodyweight /day | Lycopene, 10 mg/kg bodyweight/d | Male rats were co-administered BPA and lycopene for 3 months | Lycopene enhanced LYC glucose haemostasis, fat mass, and thyroid hormone levels, and decreased oxidative stress in BPA-treated rats | [ |
| 50 mg/kg bodyweight/d | Lycopene, 10 mg/kg bodyweight/d | 8-week-old male rats were gavaged 3 d a week for 6 weeks | BPA induced neurotoxicity in the hippocampus by eliciting oxidative stress; lycopene inhibited this effect | [ |
| 500 mg/kg bodyweight/d | Lycopene, 20 mg/kg bodyweight/d | 8-week-old female and male mice were exposed to BPA from PD8 to PD14, and to lycopene from PD1 to PD7 | Lycopene reduced the negative effect of BPA on pregnant mice | [ |
| 1 mg/kg bodyweight/d | Male mice were treated for 8 weeks | [ | ||
| 10 mg/kg bodyweight/d | Gallic acid, 20 mg/kg bodyweight/d | Male albino rats were exposed to BPA and gallic acid for 45 d | Gallic acid reduced the chronic stress caused by BPA, by increasing antioxidant enzyme levels and lowering lipid peroxidation | [ |
| 150 mg/kg bodyweight/d | Ginseng, 200 mg/kg bodyweight/d | Adult female albino rats were given BPA and ginseng from pregnancy day 0 until day 20 | Ginseng reduced testosterone and progesterone levels in BPA-treated pregnant rats | [ |
| 10 mg/kg bodyweight/d | Tualang honey, 200 mg/kg bodyweight/d | Female rats were treated for 6 consecutive weeks | BPA-induced uterine disturbance was lessened by Tualang honey owing to its phytochemical properties | [ |
| 21-year-old pre-pubertal female rats were treated for 6 consecutive weeks | Tualang honey decreased ovarian toxicity by reducing morphological abnormalities and enhancing the normal oestrous cycle | [ |
Summary of antioxidant effects alleviating bisphenol A (BPA) toxicity: evidence from in vitro models.
| BPA Dose | Target Antioxidant | Experimental Design | Mechanism of Action | Reference |
|---|---|---|---|---|
| 0, 1,10, and 100 µg/L | Superoxide dismutase (SOD) | Rat sperm and testicular tissues were incubated with BPA for 2 h | BPA exposure increased SOD activity by eliciting oxidative stress | [ |
| 0.1 to 500 µg/mL | SOD | Erythrocytes were treated with BPA for 1, 4, or 24 h | SOD activity was reduced in BPA-incubated erythrocytes | [ |
| Catalase | Catalase levels were reduced by increased number of hydrogen peroxide ions generation by BPA | |||
| Glutathione (GSH) | BPA-treated cells showed decrease GSH levels | |||
| 100 µM | GSH, 5 mM | Mouse spermatozoa were treated with BPA and glutathione for 6 h | GSH reduced oxidation and compromised acrosome integrity in BPA-exposed spermatozoa | [ |
| 100 µM | Vitamin C, 100 µM | Mouse spermatozoa were treated with BPA and glutathione for 6 h | Motility of the spermatozoa was increased and stress reduced upon vitamin C treatment | [ |
| 100 µM | Vitamin E, 2 mM | Mouse spermatozoa were treated with BPA and glutathione for 6 h | Vitamin E restored fertilization and embryo development capacity of BPA-treated cells | [ |
| 125 µM | Melatonin, 0.5 µM | Kidney mitochondria were pre-incubated with melatonin for 5 min and then exposed to BPA for 15 min | Melatonin protected mitochondrial function, reduced malondialdehyde levels, and increased GSH levels in BPA-exposed cells | [ |
| 25–150 µg/mL | Quercetin, 10–50 µg/mL | Blood samples | BPA reduced the activity of enzymatic antioxidants while quercetin ameliorated this effect | [ |
| 50 µM | Synthetic antioxidants butylated hydroxytoluene (BHT) and butylated hydroxyanisole (BHA) with rifampicin, 100 µM | 100 µM rifampicin was mixed with 0.2 µM horseradish peroxidase (HRP), 100 µM H2O2, and 50 µM phenolic compounds BHA, BHT, or BPA in 1.0 ml of 0.1 M phosphate buffer, pH 5.5; oxidation of rifampicin was then monitored for 5 min | BPA had the highest pro-oxidant activity in BHA and BHT in a rifampicin solution, which had a protective effect against oxidative stress | [ |
| 10 µM | Synthetic antioxidants BHT and BHA with NADPH, 100 µM, in 1.0 mL of phosphate buffer | 100 µM reduced NADPH was incubated with 0.2 µM HRP, 10 µM H2O2, and 10 µM BHA, BHT, or BPA in 1.0 ml of 10 mM phosphate buffer, pH 7.0, containing 50 µM DTPA; oxidation of NADPH was then monitored continuously for 5 min | BPA showed higher oxidation of NADPH compared to synthetic antioxidants | |
| 10, 20 µM | Ginseng, 75 µg/mL | Sertoli cells were cultured for 6, 24, or 48 h | Ginseng increased the activity of antioxidative enzymes, and reduced cell apoptosis and lipid peroxidation in BPA-treated cells | [ |
| 100 µM | Ginseng, 10, 25, and 50 µg/mL | Leydig and Sertoli cells were pre-treated with ginseng for 1 h and then with BPA for 24 h | Ginseng prevented apoptotic cell death and its anti-apoptotic ability could be useful for cellular defence | [ |